Related Experiment Video
Updated: Aug 7, 2026
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
[Intensity-modulated radiation combined with Delisheng injection for naspharyngeal carcinoma]
Dang Zhao1, Xing-jing Liu, Qiang Xie
1Department of Oncology, Hospital of Military police Guangdong General Team, Guangzhou 510507, China. gzxlzd@21cn.com
Objective:
To evaluate the therapeutic efficacy of intensity-modulated radiation therapy(IMRT) combined with Delisheng injection for treatment of nasopharyngeal carcinoma (NPC).
Methods:
Sixty-six patients with pathologically confirmed NPC (stage II and III) were randomized into therapeutic group and control group. Patients in the therapeutic group were treated with Delisheng injection in addition to IMRT and those in the control group with IMRT alone.
Results:
No significant difference in the response rate occurred between the two groups. The incidence of adverse effects was significantly lower in the therapeutic group than in the control group, and the humoral immunity was improved in the former.
Conclusion:
Delisheng injection can decrease the side effects of IMRT and improve humoral immunity in NPC patients.